• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Science & Environment Medical Research

Human vision restored by stem cell replacement in regenerative medicine breakthrough

November 12, 2024
in Medical Research
Reading Time: 3 mins read
A A
0
Human vision restored by stem cell replacement in regenerative medicine breakthrough
1
SHARES
3
VIEWS
Share on FacebookShare on Twitter


Fabrication and transplantation of human iCEPSs. Credit: The Lancet (2024). DOI: 10.1016/S0140-6736(24)01764-1

Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency, offering a potential new avenue for restoring vision.

Limbal stem cell deficiency (LSCD) is a severe ocular condition where the loss of functioning adult stem cells at the cornea’s edge leads to vision impairment due to the invasion of fibrotic conjunctival tissue over the cornea. Limbal stem cells normally perform repair functions by differentiating into corneal epithelium. Without them, the integrity and transparency of the corneal surface becomes compromised, leading to fibrotic tissue buildup, and ultimately, vision loss.

Traditional treatments often involve grafts from the patient’s healthy eye or donors, but these methods carry risks like immunological rejection, or require the removal of healthy tissue.

In a study titled “Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan,” published in The Lancet, researchers conducted transplants of pluripotent stem cell (iPSC)-derived corneal epithelial sheets (iCEPS) as a potential treatment for LSCD.

Four patients with LSCD participated in the study. After removing any fibrotic tissue, the team transplanted allogeneic iCEPS onto the affected eyes. All surgeries were performed without human leukocyte antigen (HLA) matching. Half the patients received low-dose cyclosporine (typically used to mitigate organ rejection after a transplant), while the other half received no immunosuppressive agents beyond corticosteroids.

Two years of monitoring revealed no severe adverse events. Minor adverse events were managed effectively and without lasting effects.

All four patients experienced significant improvements in vision. Disease stages advanced to less severe classifications in three patients. One patient, with a more severe underlying condition, initially improved to a less severe stage by 32 weeks, but later regressed to baseline after one year. Quality-of-life assessments aligned with visual improvements, with three of the four patients reporting enhanced scores.

Overall, the study demonstrated that iCEPS transplantation not only stabilizes the corneal surface but also restores functional vision, significantly enhancing the daily lives of patients with limbal stem cell deficiency. Beneficial outcomes were more pronounced in patients who received low-dose cyclosporine, suggesting that non-use might have triggered subclinical immunological rejection.

The iCEPS were cultivated using a method that replicates aspects of natural eye development to produce functional corneal cells. This technique not only ensures the structural integrity of the grafts but also reduces immunogenicity, potentially eliminating the need for HLA matching and extensive immunosuppression typically required in traditional grafts.

The successful result is a major therapeutic advancement, building on earlier successes in regenerative medicine while overcoming the limitations of existing LSCD surgical treatments. The Osaka team plans to initiate a larger multicenter clinical trial to further validate the findings and explore the broader applicability of iCEPS transplantation.

More information:
Takeshi Soma et al, Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan, The Lancet (2024). DOI: 10.1016/S0140-6736(24)01764-1

© 2024 Science X Network

Citation:
Human vision restored by stem cell replacement in regenerative medicine breakthrough (2024, November 12)
retrieved 12 November 2024
from

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



Fabrication and transplantation of human iCEPSs. Credit: The Lancet (2024). DOI: 10.1016/S0140-6736(24)01764-1

Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived corneal epithelium to treat limbal stem cell deficiency, offering a potential new avenue for restoring vision.

Limbal stem cell deficiency (LSCD) is a severe ocular condition where the loss of functioning adult stem cells at the cornea’s edge leads to vision impairment due to the invasion of fibrotic conjunctival tissue over the cornea. Limbal stem cells normally perform repair functions by differentiating into corneal epithelium. Without them, the integrity and transparency of the corneal surface becomes compromised, leading to fibrotic tissue buildup, and ultimately, vision loss.

Traditional treatments often involve grafts from the patient’s healthy eye or donors, but these methods carry risks like immunological rejection, or require the removal of healthy tissue.

In a study titled “Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan,” published in The Lancet, researchers conducted transplants of pluripotent stem cell (iPSC)-derived corneal epithelial sheets (iCEPS) as a potential treatment for LSCD.

Four patients with LSCD participated in the study. After removing any fibrotic tissue, the team transplanted allogeneic iCEPS onto the affected eyes. All surgeries were performed without human leukocyte antigen (HLA) matching. Half the patients received low-dose cyclosporine (typically used to mitigate organ rejection after a transplant), while the other half received no immunosuppressive agents beyond corticosteroids.

Two years of monitoring revealed no severe adverse events. Minor adverse events were managed effectively and without lasting effects.

All four patients experienced significant improvements in vision. Disease stages advanced to less severe classifications in three patients. One patient, with a more severe underlying condition, initially improved to a less severe stage by 32 weeks, but later regressed to baseline after one year. Quality-of-life assessments aligned with visual improvements, with three of the four patients reporting enhanced scores.

Overall, the study demonstrated that iCEPS transplantation not only stabilizes the corneal surface but also restores functional vision, significantly enhancing the daily lives of patients with limbal stem cell deficiency. Beneficial outcomes were more pronounced in patients who received low-dose cyclosporine, suggesting that non-use might have triggered subclinical immunological rejection.

The iCEPS were cultivated using a method that replicates aspects of natural eye development to produce functional corneal cells. This technique not only ensures the structural integrity of the grafts but also reduces immunogenicity, potentially eliminating the need for HLA matching and extensive immunosuppression typically required in traditional grafts.

The successful result is a major therapeutic advancement, building on earlier successes in regenerative medicine while overcoming the limitations of existing LSCD surgical treatments. The Osaka team plans to initiate a larger multicenter clinical trial to further validate the findings and explore the broader applicability of iCEPS transplantation.

More information:
Takeshi Soma et al, Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan, The Lancet (2024). DOI: 10.1016/S0140-6736(24)01764-1

© 2024 Science X Network

Citation:
Human vision restored by stem cell replacement in regenerative medicine breakthrough (2024, November 12)
retrieved 12 November 2024
from

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.


Tags: Health ResearchHealth Research NewsHealth ScienceMedicine ResearchMedicine Research NewsMedicine Science
Previous Post

Lebanon’s displaced brace for winter as ceasefire hopes fade

Next Post

U.S. acts to cut methane pollution

Related Posts

woman uncomfortable

Most young women suffer from itching, irritation, pain and other symptoms in genital area, Brazilian study finds

May 28, 2025
4

Texas Lawmakers Look to Make Child Vaccine Exemptions Easier for Parents as Measles Outbreak Continues

May 28, 2025
2
Next Post
Bureau of Land Management releases arctic lease sale analysis

U.S. acts to cut methane pollution

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
woman uncomfortable

Most young women suffer from itching, irritation, pain and other symptoms in genital area, Brazilian study finds

May 28, 2025
Andry Hernandez Romero venezuela

Immigration courts are quietly tossing out the cases of Alien Enemies Act deportees

May 28, 2025

Trump pardons former GOP Rep. Michael Grimm amid clemency spree

May 28, 2025
Russia sanctions probably backfired, as in apartheid South Africa

Russia sanctions probably backfired, as in apartheid South Africa

May 28, 2025

Recent News

woman uncomfortable

Most young women suffer from itching, irritation, pain and other symptoms in genital area, Brazilian study finds

May 28, 2025
4
Andry Hernandez Romero venezuela

Immigration courts are quietly tossing out the cases of Alien Enemies Act deportees

May 28, 2025
3

Trump pardons former GOP Rep. Michael Grimm amid clemency spree

May 28, 2025
4
Russia sanctions probably backfired, as in apartheid South Africa

Russia sanctions probably backfired, as in apartheid South Africa

May 28, 2025
4

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

woman uncomfortable

Most young women suffer from itching, irritation, pain and other symptoms in genital area, Brazilian study finds

May 28, 2025
Andry Hernandez Romero venezuela

Immigration courts are quietly tossing out the cases of Alien Enemies Act deportees

May 28, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co